Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma (Q36025069)

11 August 2017

Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma (English)

1 reference

11 August 2017

1 reference

1 reference

2

Craig R Rayner

1 reference

11 August 2017

Sreeja Sudhakaran

1

1 reference

11 August 2017

Jian Li

3

1 reference

11 August 2017

David C M Kong

4

1 reference

11 August 2017

Neil M Gude

5

1 reference

11 August 2017

Roger L Nation

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

19 September 2006

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

63

1 reference

11 August 2017

3

1 reference

11 August 2017

315-321

1 reference

Differential bidirectional transfer of indinavir in the isolated perfused human placenta

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Drug transfer and metabolism by the human placenta.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

HIV-1 protease inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Weak Binding of VX-478 to Human Plasma Proteins and Implications for Anti-Human Immunodeficiency Virus Therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Plasma protein binding of drugs in pregnancy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Plasma protein binding of drugs in pregnancy and in neonates

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

2 October 2017

HIV-protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Drug disposition in mother and foetus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

11 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02766.X

Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02766.X

Transplacental passage of protease inhibitors at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02766.X

The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02766.X

The binding of HIV-1 protease inhibitors to human serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02766.X

The utility of inhibitory quotients in determining the relative potency of protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02766.X

Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000742

Drug distribution in whole blood of mothers and their newborn infants: studies of cloxacillin and flucloxacillin

23 September 2018

1 reference

12 December 2020

Meperidine binding in maternal and fetal plasma

1 reference

12 December 2020

Naloxone protein binding in adult and foetal plasma

1 reference

12 December 2020

Differential binding of warfarin to maternal, foetal and non-pregnant sera and its clinical implications

1 reference

12 December 2020

10.1111/J.1365-2125.2006.02766.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

16981898

1 reference